$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000159552724000011 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$15.75M	$15.48M
YoY Change	-0.18%	-0.34%
Cost Of Revenue	$10.39M	$10.29M
YoY Change	0.45%	-0.19%
Gross Profit	$5.366M	$5.196M
YoY Change	-1.38%	-0.63%
Gross Profit Margin	34.06%	33.56%
Selling, General & Admin	$2.150M	$2.855M
YoY Change	-54.67%	-46.94%
% of Gross Profit	40.07%	54.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.151M	$5.261M
YoY Change	-23.68%	-24.32%
% of Gross Profit	95.99%	101.25%
Operating Expenses	$7.301M	$8.116M
YoY Change	-36.47%	-34.19%
Operating Profit	-$86.66M	-$2.920M
YoY Change	1297.28%	-58.9%
Interest Expense	$5.201M	$4.697M
YoY Change	10.5%	0.73%
% of Operating Profit
Other Income/Expense, Net	-$5.192M	-$4.688M
YoY Change	10.54%	0.73%
Pretax Income	-$91.85M	-$7.608M
YoY Change	742.75%	-35.3%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$91.85M	-$7.608M
YoY Change	742.75%	-35.3%
Net Earnings / Revenue	-583.03%	-49.14%
Basic Earnings Per Share	-$36.48	-$3.28
Diluted Earnings Per Share	-$36.48	-$3.28
COMMON SHARES
Basic Shares Outstanding	2.579M shares	2.405M shares
Diluted Shares Outstanding	2.518M shares	2.323M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.222M	$5.293M
YoY Change	-25.95%	-39.53%
Cash & Equivalents	$5.222M	$5.293M
Short-Term Investments
Other Short-Term Assets	$5.642M	$5.908M
YoY Change	1.84%	-2.86%
Inventory
Prepaid Expenses
Receivables	$30.63M	$30.78M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$41.50M	$41.98M
YoY Change	-0.72%	-4.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$541.0M	$630.3M
YoY Change	-24.53%	-12.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.42M	$17.52M
YoY Change	4.63%	-3.74%
Total Long-Term Assets	$557.4M	$647.8M
YoY Change	-24.03%	-12.71%
TOTAL ASSETS
Total Short-Term Assets	$41.50M	$41.98M
Total Long-Term Assets	$557.4M	$647.8M
Total Assets	$598.9M	$689.8M
YoY Change	-22.77%	-12.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.81M	$15.49M
YoY Change	31.27%	18.11%
Accrued Expenses	$54.63M	$54.64M
YoY Change	-0.11%	-0.11%
Deferred Revenue
YoY Change
Short-Term Debt	$150.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$70.59M	$70.13M
YoY Change	5.78%	3.41%
LONG-TERM LIABILITIES
Long-Term Debt	$396.5M	$396.1M
YoY Change	0.39%	0.39%
Other Long-Term Liabilities	$5.086M	$6.215M
YoY Change	-19.65%	-19.98%
Total Long-Term Liabilities	$401.6M	$402.3M
YoY Change	0.07%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$70.59M	$70.13M
Total Long-Term Liabilities	$401.6M	$402.3M
Total Liabilities	$472.1M	$472.4M
YoY Change	0.89%	0.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$604.7M	-$512.9M
YoY Change	43.3%	24.76%
Common Stock	$26.00K	$24.00K
YoY Change	13.04%	4.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$126.8M	$217.4M
YoY Change
Total Liabilities & Shareholders Equity	$598.9M	$689.8M
YoY Change	-22.77%	-12.27%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$91.85M	-$7.608M
YoY Change	742.75%	-35.3%
Depreciation, Depletion And Amortization	$5.151M	$5.261M
YoY Change	-23.68%	-24.32%
Cash From Operating Activities	-$916.0K	$1.655M
YoY Change	-73.33%	-323.05%
INVESTING ACTIVITIES
Capital Expenditures	$204.0K	$364.0K
YoY Change	-58.62%	-84.23%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$204.0K	-$364.0K
YoY Change	-58.62%	-84.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	150.0K	$0.00
YoY Change	-1600.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-916.0K	$1.655M
Cash From Investing Activities	-204.0K	-$364.0K
Cash From Financing Activities	150.0K	$0.00
Net Change In Cash	-970.0K	$1.291M
YoY Change	-75.37%	31.07%
FREE CASH FLOW
Cash From Operating Activities	-$916.0K	$1.655M
Capital Expenditures	$204.0K	$364.0K
Free Cash Flow	-$1.120M	$1.291M
YoY Change	-71.49%	-142.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54657000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2061000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3983000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	469378000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2403994	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729644000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	406000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-505279000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	224794000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54641000	usd
CY2024Q1	us-gaap	Below Market Lease Net BelowMarketLeaseNet	1848000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4367000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	472432000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2403994	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	730230000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-512887000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	217367000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689799000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	694172000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15481000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15534000	usd
CY2024Q1	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1903000	usd
CY2023Q1	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1884000	usd
CY2024Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8382000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8421000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2200000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2801000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3181000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5261000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6952000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	18401000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	22638000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2920000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7104000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	4697000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	4663000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4688000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4654000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7608000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11758000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7608000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11758000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-406000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-382000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-406000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-382000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8014000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12140000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2322594	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2322594	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2038880	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2038880	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.28
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2322594	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2322594	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2038880	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2038880	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.28
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	224794000	usd
CY2024Q1	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	533000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	54000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7608000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-406000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	217367000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
CY2023Q1	nycr	Stock Issued During Period Value Warrants And Rights StockIssuedDuringPeriodValueWarrantsAndRights	4059000	usd
CY2023Q1	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	485000	usd
CY2023Q1	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	24000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2200000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-11758000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-382000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	316156000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7608000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-11758000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5261000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6952000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	386000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	386000	usd
CY2024Q1	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	55000	usd
CY2023Q1	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	-36000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2200000	usd
CY2024Q1	nycr	Management Fees Reinvested ManagementFeesReinvested	533000	usd
CY2023Q1	nycr	Management Fees Reinvested ManagementFeesReinvested	485000	usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	30000	usd
CY2023Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	204000	usd
CY2024Q1	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	27000	usd
CY2023Q1	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	27000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-234000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	865000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2470000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1193000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	383000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	806000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1655000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-742000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	364000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2308000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-364000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2308000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4059000	usd
CY2024Q1	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
CY2023Q1	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	24000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4035000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1291000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	985000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14099000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17102000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5293000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8753000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P42Y9M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54700000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8806000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8349000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14099000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17102000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	4321000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	4190000	usd
CY2024Q1	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	43000	usd
CY2023Q1	nycr	Increase Decrease In Accrued Capital Expenditures IncreaseDecreaseInAccruedCapitalExpenditures	-867000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	533000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	485000	usd
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	7	property
CY2024Q1	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
CY2024Q1	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y3M18D
CY2024Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	716300000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54600000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	49500000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	99000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	140000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	60000000	usd
CY2024Q1	nycr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	51000000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	399500000	usd
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	66000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q1	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	400000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	400000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2400000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2300000	shares
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3560000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	usd
CY2024Q1	nycr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	188262000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	210806000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	156165000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	54641000	usd
CY2024Q1	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3295000	usd
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3245000	usd
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	30	trading_day
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	10	trading_day
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2024Q1	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
CY2024Q1	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7608000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11758000	usd
CY2024Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7608000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11758000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2322594	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2322594	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2038880	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2038880	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.28
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35025	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	521709	shares
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001595527-24-000011-index-headers.html	Edgar Link	pending
0001595527-24-000011-index.html	Edgar Link	pending
0001595527-24-000011.txt	Edgar Link	pending
0001595527-24-000011-xbrl.zip	Edgar Link	pending
ex311asic3312024.htm	Edgar Link	pending
ex312asic3312024.htm	Edgar Link	pending
ex32asic33124.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20240331.htm	Edgar Link	pending
nycr-20240331.xsd	Edgar Link	pending
nycr-20240331_g1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nycr-20240331_cal.xml	Edgar Link	unprocessable
nycr-20240331_def.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
nycr-20240331_lab.xml	Edgar Link	unprocessable
nycr-20240331_pre.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nycr-20240331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2024 Q2 Form 10-Q Financial Statement

#000159552724000011 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2024 Q2 Form 10-Q Financial Statement

#000159552724000011 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc